Malvern, PA, United States of America

Lawrence Rosen

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Lawrence Rosen

Introduction

Lawrence Rosen is a notable inventor based in Malvern, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of beta-lactamase inhibitors. With a total of 3 patents to his name, his work has the potential to impact the treatment of bacterial infections.

Latest Patents

One of his latest patents is titled "Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof." This patent describes crystalline forms of (R)-3-(2-(trans-4-(2-aminoethylamino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid. In some embodiments, these crystalline forms are formulated for treating subjects in need of intervention due to bacterial infections.

Career Highlights

Lawrence Rosen is currently associated with Venatorx Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing new treatments that can effectively combat resistant bacterial strains.

Collaborations

He collaborates with esteemed colleagues such as Christopher J Burns and Daniel C Pevear, contributing to a dynamic research environment that fosters innovation.

Conclusion

Lawrence Rosen's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His work is crucial in the ongoing battle against bacterial infections, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…